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UNIT A1.6Rule Out (R/O) Vasculitis
When imaging patients for vasculitis, the goals are (1) to determine if there is evidence
of acute or subacute cerebral injury and (2) to assess the contour of the major intracranial
arteries. An additional but still experimental goal is (3) to determine if there are areas
of altered perfusion that suggest active small vessel disease. Standard MR images and
diffusion-weighted imaging are used to detect and determine the age of parenchymal
lesions. The 3-D TOF MRA helps evaluate the large and medium vessels. Perfusion-
weighted imaging may detect regions of altered relative blood flow and blood volume.
The followingBasic Protocol can be used for the evaluation of stable patients; anAlternate
Protocol is provided for evaluation of unstable patients.
BASIC
PROTOCOL
STANDARD IMAGING FOR VASCULITIS
In order to perform the optional sequences with perfusion and diffusion studies, a scanner
with echoplanar capabilities is required (Table A1.6.1).MR angiography and the standard
anatomical MR imaging sequences included in the protocols do not require these faster
gradients. The parameters given here are optimized for a 1.5T GE LX system with 11.0
software and may need modification for different software versions, field strengths, or
manufacturers.
Data processing is required for the 3-D TOF MRA sequences described in this unit. For
optimal assessment of the volumetric 3-D TOF MRA data, separate volumes of interest
(VOI) of the left anterior, right anterior, and posterior circulation should be created.
Images from 15◦ rotations about the vertical axis should be saved. An additional anterior
circulation volume of interest should include both anterior cerebral arteries and the region
of the anterior communicating artery for visual inspection. Images from 15◦ rotations
about the horizontal axis should be saved.
Table A1.6.1 Equipment Requirements for Cerebral Vascular Assessment
Type of system LX EchoSpeed
Field strength 1.5 T
Software level 11
Magnet type CX K4
Polarity Positive
Active gradient shielding No
Passive gradient shielding No
Gradient strength (amplitude) 2.4 mT/cm
Slew rate 12 mgauss/cm
SAR (average) 2 W/kg
SAR (max) 8 W/kg
Superior conductive shimming 45 cm
Resistive shimming No
Active magnetic shielding No
Maximum noise level 100 db
Type of body coil High pass
TPS recon system memory 386
Array processor (TPS) Reflex 100
Computer LX Octane
Weight limit 350 lb (130.6 kg)
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Although maximum intensity projections are used. All of the authors’ MRA data is
processed on a General Electric (GE) Advantage Windows Workstation version 3.1P
using standard GEAdvantageWindows software or FuncTool version 1.9M. In the hands
of an experienced technologist, the post-processing will require ∼5 min.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen. Reactions to contrast agents are rare, but the
resources are necessary.
Materials
Gadolinium-DTPA contrast agent (e.g., Manevist, Omniscan, Prohance)
Normal saline (0.9% NaCl), sterile
Injection pump
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no counterindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also be
sure to find out if the patient has any health conditions that may require the presence
of special emergency equipment during the scanning procedure, or necessitate any
other precautions. Do not forget to ask if the patient has any drug allergies and
document them.
Generally, standard screening forms are used for all patients scanned in a magnetic
resonance system (see APPENDIX 1).
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with anymetal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be
able to communicate with the technologist at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For optimum results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
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6. Have the patient mount onto the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be used.
7. Establish an intravenous line using an 18-G angiocatheter through which the contrast
agent can be injected, and attach this line securely to the patient so that movement
into or out of the magnet will not pull at the patient’s arm.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet, so
that there is no intervening motion between the scans run before contrast agent injection
and those run after injection.
8. Center the patient in a head or neck coil at the region where the key information
is desired. Make sure that the head and neck are constrained to prevent motion,
especially if high-resolution scans are to be run.
Generally, the patient’s head is fixed so that the head is horizontal (not tilted) and the
neck and head lie along the axis of the patient table; other positions may be appropriate
depending on the needs at hand.
Most scanners have a special neck coil for MRA; otherwise, a head coil should be used
and the patient placed as far in as possible so that the bifurcation of the main carotid
artery into the internal and external carotid arteries can be imaged.
9. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
10. Place the patient such that the laser light is centered over the patient’s nasion, and
put him or her into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table,
the table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
11. If the patient is unable to hold still, provide an appropriate sedative.
12. Connect the MR-compatible injection pump, cleared of air, and loaded with a double
dose of contrast agent and saline flush, to the patient. Do a small test injection of
normal saline to ensure that the i.v. is working properly.
13. Program the 5 ml/sec injection rate for both contrast and saline, the contrast dose
required (double dose by weight), the saline flush required (typically 40 ml), and a
10-sec time delay. Start the saline running at TKVO (to keep vein open) and arm the
injection pump.
Sequence 1: Rapid sagittal T1-weighted scout
14. To validate the patient’s position, perform a fast sagittal scout scan using the imaging
sequence in Table A1.6.2.
Some centers may prefer a rapid three-plane scout instead of this multislice sagittal scout.
Sequence 2: Transverse diffusion
15. From the sagittal scout, select the image through the center of the brain to set up
the locations for the transverse diffusion. The transverse images should begin at the
foramenmagnum and end at the top of the brain. Set up imaging parameters as shown
in Table A1.6.3.
16. Warn the patient that this sequence results in loud beeping noises and begin the scan.
Most diffusion sequenceswill performaminimumof four sequences: threewith orthogonal
diffusion gradient directions and one with a minimal or no diffusion gradient. Often, a
fifth set of images is also provided which combines the three orthogonal gradient images
to produce a set of images whose signal intensity is not affected by the diffusion direction.
This is diffusion-weighted imaging (DWI). In order to obtain apparent diffusion coefficient
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Table A1.6.2 Rapid Sagittal T1-Weighted Scout
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Nasion
Echo time (TE) Minimum (at least 4.1 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 100 msec
Flip angle (FA) 60◦
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (x, y) 0.94 mm, 1.87 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 7 mm
Number of slices 7
Slice gap 2 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Scan time 16 sec
Table A1.6.3 Transverse Diffusion
Patient position Supine
Scan type SE-EPI
Imaging plane (orientation) Transverse
Central slice or volume center Nasion
Echo time (TE) Minimum (80.9 msec)
Echo train length (ETL) or shots (SH) 1 SH
Repeat time (TR) 5000 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 3
Number of acquisitions (Nacq) 1
Read direction Right–left
Saturation pulses Fat saturation (automatic with EPI)
Control variables (CV) Ramp sampling = 1,
burst sampling = 0
b-value 1000 sec/min2
Direction 6 sec
Scan time 3 min, 5 sec
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Table A1.6.4 Transverse FLAIR
Patient position Supine
Scan type Inversion recovery, FSE
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 120 msec
Receiver bandwidth (RBW) 20.83 kHz
Repeat time (TR) 10,000 msec
Inversion time (TI) 2200 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Saturation pulses Inferior
Scan time 4 min, 44 sec
Table A1.6.5 Transverse T2-Weighted FSE
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) FSE-XL
Central slice or volume center Nasion
Echo time (TE) 102 msec
Receiver bandwidth (RBW) 11.36 kHz
Echo train length (ETL) or shots (SH) 12
Repeat time (TR) 6000 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 0.86 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 320, 256
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Flow compensation Yes
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 3 min, 19 sec
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(ADC) maps, the images may need further processing. On a GE system, the ADC maps
can be obtained by processing on the Advantage Window Workstation using FuncTool
version 1.9M.
Sequence 3: Transverse FLAIR
17. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse FLAIR. The locations should be the same as those chosen
for the transverse diffusion. Set up the imaging parameters as shown in Table A1.6.4.
18. Warn the patient that this sequence is starting and begin the scan.
Sequence 4: Transverse T2-weighted FSE
19. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse T2-weighted FSE. The locations should be the same as
those chosen for the transverse diffusion. Set up the imaging parameters as shown in
Table A1.6.5.
20. Warn the patient that this sequence is starting and begin the scan.
Table A1.6.6 Transverse 3-D TOF MRA
Patient position Supine
Scan type 3-D vascular TOF SPGR
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 6.9 msec
Receiver bandwidth (RBW) 10.42 kHz
Repeat time (TR) 50 msec
Flip angle (FA) 20◦
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (x, y) 0.357 mm, 0.468 mm
Number of data points collected (Nx, Ny) 384, 224
Display matrix (Dx, Dy) 384, 224
Slice thickness (z) 1.4 mm
Number of slices/slab 40
Number of slabs 2
Slab overlap 4
Slice gap 0
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Flow compensation Yes
ZIP 512/ZIP 1024 ZIP 512
ZIP 2/ZIP 4 ZIP 2
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Magnetization transfer Yes
Vascular options Reprojections = 19,
collapse = on,
ramp pulse = inferior to superior
Scan time 6 min, 32 sec
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Sequence 5: Transverse 3-D TOF MRA
21. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse 3-D TOFMRA. Set up the imaging parameters as shown
in Table A1.6.6. Two slabs are posted on the midline sagittal image, centered at the
top of the sella tursica.
22. Warn the patient that this sequence is starting and begin the scan.
This sequence can also be performed after Sequence 7 (perfusion sequence) to optimize
visualization of small vessels.
Data processing and viewing for Sequence 5
23. Once the axial partitions from the 3-D TOF are obtained, select volumes of interest
(VOI) that select out the posterior circulation, the right anterior circulation, and the
left anterior circulation. Rotate the maximum intensity projections (MIPs) or surface
reconstructions of these three VOIs through 360◦ about the vertical, saving images at
15◦ intervals. Rotate a fourth VOI that selects out both anterior circulations through
360◦ about the horizontal, saving images at 15◦ intervals.
Sequence 6: Transverse T1-weighted spin echo
24. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse T1-weighted spin echo. The locations should be the same
as those chosen for the transverse diffusion. Set up the imaging parameters as shown
in Table A1.6.7.
25. Warn the patient that this sequence is starting and begin the scan.
Table A1.6.7 Transverse T1-Weighted Spin Echo
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) Minimum full (14 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 400 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Flow compensation No
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 2 min, 8 sec
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Table A1.6.8 Transverse Perfusion
Patient position Supine
Scan type GRE-EPI
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 54 msec
Echo train length (ETL) 1
Repeat time (TR) 1500 msec
Flip angle (FA) 35◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Right–left
Slice location Inferior slice to include MCA
Multiphase Yes, 46 phases per location,
minimum delay between acquisition
Slice series Interleaved
Control variables (CV) Ramp sampling = on,
burst sampling = off
Scan time 1 min, 10 sec
Sequence 7: Transverse perfusion
26. Using the transverse T2-weighted FSE images, find the slice location where the
middle cerebral arteries are best seen. Using the imaging parameters as shown in
Table A1.6.8, set up the transverse images starting at the same location as the MCA
were identified on the FSE T2.
Typically only ten or eleven slices can be obtained in the given TR interval. The slice thick-
ness and gap can be modified so that the perfusion study covers any diffusion abnormality.
27. Check that the injection pump is ready to inject and that the injection is set to start
after a 10-sec delay.
28. Warn the patient that this sequence is starting and that part way through the scan, the
i.v. injection will occur. Begin the scan.
29. Process the perfusion images using appropriate workstation and software to give
maps of relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF),
and mean transit time (MTT).
On a GE system, one can use an Advantage Windows Workstation with FuncTool version
1.9M.
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Table A1.6.9 Transverse Post-Contrast T1-Weighted Spin Echo
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) Minimum full (20 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 400 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Flow compensation Yes
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 2 min, 8 sec
Table A1.6.10 Coronal Post-Contrast T1-Weighted Spin Echo
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) Minimum full (20 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 26
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Superior-inferior
Flow compensation Yes
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 2 min, 40 sec
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Sequence 8: Transverse post-contrast T1
30. From the sagittal scout, select the image through the center of the brain to set up the
locations for the coronal post-contrast T1. The locations should be the same as those
chosen for the transverse diffusion. Set up the imaging parameters as shown in Table
A1.6.9.
31. Warn the patient that this sequence is starting and begin the scan.
Sequence 9: Coronal post-contrast T1
32. From the sagittal scout, select the image through the center of the brain to set up
the locations for the coronal post-contrast T1. The locations should be the same as
those chosen for the transverse diffusion. Set up the imaging parameters as shown in
Table A1.6.10.
33. Warn the patient that this sequence is starting and begin the scan.
ALTERNATE
PROTOCOL
RAPID ASSESSMENT FOR ALTERED PERFUSION AND ACUTE ISCHEMIC
INJURY
To evaluate an unstable patient, imaging must be kept to a minimum. In such cases, the
following alternate protocol should be followed.
Set up patient and equipment
1. Perform equipment and patient setup as in steps 1 to 11 of the Basic Protocol.
2. Draw up a syringe with a single dose of contrast by weight (typically 20 ml).
3. Perform Sequences 1 to 4 as described in the Basic Protocol.
4. Perform Sequence 8 as described in the Basic Protocol.
COMMENTARY
Background Information
Reports on the sensitivity of standard MR
images versus catheter angiography vary and
one or both can be normal. Standard MR
studies and catheter angiography actually ap-
pear to provide complimentary information
(Greenan et al., 1992; Harris et al., 1994; Duna
and Calabrese, 1995; Cloft et al., 1999; Pom-
per et al., 1999) Recently, perfusion-weighted
imaging has been shown to detect regions
of altered hemodynamics, presumably related
to microvascular involvement, that were not
identified on catheter angiography (Yuh et al.,
1999a,b). Diffusion-weighted imaging may
also add additional information by identifying
regions of acute necrotic change in a nonvas-
cular territory (Yuh et al., 1999b). Although in
most cases, 3-D TOF angiography is unhelp-
ful because vascular involvement is limited
to small vessels, 3-D TOF angiography may
be helpful when medium to large vessels are
involved, such as in vasculitis due to fungal in-
vasion. Post-contrast studies are routinely ob-
tained to assess for blood-brain barrier break-
downdue tovasculitic involvement thatmaybe
reversible, blood-brain barrier breakdown due
to subacute ischemic events, and dural pathol-
ogy. The presence of dural sinus pathology
or brain stem atrophy in addition to multifo-
cal parenchymal involvement raises the possi-
bility of Neurological Becet’s disease. Dural
enhancement has also been reported in tem-
poral arteritis (Joelson et al., 2000). FLAIR
images are also included as they may im-
prove detection of subtle subcortical lesions
when compared to T2 FSE images (Jager et al.,
1999).
Critical Parameters and
Troubleshooting
With FLAIR sequences, it is important to
make sure that the TR and TI values have not
been modified and that vendor-specific recom-
mendations for optimal CSF suppression have
been followed. For example in GE FLAIR se-
quences, at least two interleaved acquisitions
are required for optimal CSF suppression.
Important basic parameters in MR angiog-
raphy are as discussion in UNIT A1.1. With the
post-contrast MRA, the TR can be decreased
Intracranial
Arterial Disease
A1.6.11
Current Protocols in Magnetic Resonance Imaging Supplement 13
and the flip angle increased compared to the
precontrast study to improve visualization.
Anticipated Results
This combination of sequences should al-
low the detection and distinction of acute from
chronic parenchymal injury. The perfusion-
weighted sequence should allow regions with
altered hemodynamics to be identified. These
regions of altered hemodynamicsmay indicate
acute small vessel involvement prior to the de-
velopment of acute infarction. In the rare cases
that medium or large vessels are involved,
the MRA may help identify areas of involve-
ment. The post-contrast studies should allow
detection of dural involvement and also allow
detection of regions of blood brain barrier
breakdown due to either the vasculitis or re-
lated ischemic lesions.
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